AUXILIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 05334DAA5. A total of 36 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $3,508,000 | -57.5% | 2,364,000 | -62.2% | 0.01% | -58.8% |
Q3 2014 | $8,245,000 | +21.8% | 6,252,000 | -0.0% | 0.02% | +13.3% |
Q2 2014 | $6,769,000 | -12.1% | 6,253,000 | +7.3% | 0.02% | -11.8% |
Q1 2014 | $7,702,000 | -14.4% | 5,829,000 | -28.3% | 0.02% | -22.7% |
Q4 2013 | $8,995,000 | -7.2% | 8,131,000 | -13.2% | 0.02% | -15.4% |
Q3 2013 | $9,693,000 | +37.2% | 9,371,000 | +127831.7% | 0.03% | +23.8% |
Q2 2013 | $7,064,000 | – | 7,325 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 22,144 | $24,659,000 | 1.74% |
Baker Brothers Advisors | 87,090,000 | $96,343,000 | 1.36% |
SYMPHONY ASSET MANAGEMENT LLC | 10,000,000 | $11,063,000 | 0.81% |
WOLVERINE ASSET MANAGEMENT LLC | 35,608,000 | $39,670,000 | 0.78% |
Pinnacle Holdings, LLC | 2,110,000 | $2,337,374,000 | 0.68% |
Man Investments (CH) AG | 1,200,000 | $1,337,000 | 0.55% |
ADVENT CAPITAL MANAGEMENT /DE/ | 28,969,000 | $32,352,000 | 0.41% |
Visium Asset Management, LP | 13,000,000 | $14,461,000 | 0.28% |
PALISADE CAPITAL MANAGEMENT, LP | 7,380,000 | $8,240,000 | 0.21% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,500,000 | $2,771,000 | 0.14% |